Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 796Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development

Gupta Sandeep Kumar

Year : 2011| Volume: 2| Issue : 4 | Page no: 121-123

   This article has been cited by
1 Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects
Ying Huang,Pryseley Nkouibert Assam,Cong Feng,Rong Su,Paul Dorinsky,Michael Gillen
Pulmonary Pharmacology & Therapeutics. 2020; : 101976
[Pubmed]  [Google Scholar] [DOI]
2 New paradigm for expediting drug development in Asia
Iris Rajman,Masaru Hirano,Wataru Honma,Sylvia Zhao
Drug Discovery Today. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review
Pi-Lin Sung,Yen-Hou Chang,Kuan-Chong Chao,Chi-Mu Chuang
Gynecologic Oncology. 2014;
[Pubmed]  [Google Scholar] [DOI]
4 In Silieo Study on the Inhibitory Interaction of Drugs with Wild-type CYP2D6.1 and the Natural Variant CYP2D6.17
Koichi Handa,Izumi Nakagome,Noriyuki Yamaotsu,Hiroaki Gouda,Shuichi Hirono
Drug Metabolism and Pharmacokinetics. 2014; 29(1): 52
[Pubmed]  [Google Scholar] [DOI]


Read this article